Cargando…

SARS-Cov-2RNA found on particulate matter of Bergamo in Northern Italy: First evidence

BACKGROUND: The burden of COVID-19 was extremely severe in Northern Italy, an area characterized by high concentrations of particulate matter (PM), which is known to negatively affect human health. Consistently with evidence already available for other viruses, we initially hypothesized the possibil...

Descripción completa

Detalles Bibliográficos
Autores principales: Setti, Leonardo, Passarini, Fabrizio, De Gennaro, Gianluigi, Barbieri, Pierluigi, Perrone, Maria Grazia, Borelli, Massimo, Palmisani, Jolanda, Di Gilio, Alessia, Torboli, Valentina, Fontana, Francesco, Clemente, Libera, Pallavicini, Alberto, Ruscio, Maurizio, Piscitelli, Prisco, Miani, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260575/
https://www.ncbi.nlm.nih.gov/pubmed/32526492
http://dx.doi.org/10.1016/j.envres.2020.109754
_version_ 1783540345713197056
author Setti, Leonardo
Passarini, Fabrizio
De Gennaro, Gianluigi
Barbieri, Pierluigi
Perrone, Maria Grazia
Borelli, Massimo
Palmisani, Jolanda
Di Gilio, Alessia
Torboli, Valentina
Fontana, Francesco
Clemente, Libera
Pallavicini, Alberto
Ruscio, Maurizio
Piscitelli, Prisco
Miani, Alessandro
author_facet Setti, Leonardo
Passarini, Fabrizio
De Gennaro, Gianluigi
Barbieri, Pierluigi
Perrone, Maria Grazia
Borelli, Massimo
Palmisani, Jolanda
Di Gilio, Alessia
Torboli, Valentina
Fontana, Francesco
Clemente, Libera
Pallavicini, Alberto
Ruscio, Maurizio
Piscitelli, Prisco
Miani, Alessandro
author_sort Setti, Leonardo
collection PubMed
description BACKGROUND: The burden of COVID-19 was extremely severe in Northern Italy, an area characterized by high concentrations of particulate matter (PM), which is known to negatively affect human health. Consistently with evidence already available for other viruses, we initially hypothesized the possibility of SARS-CoV-2 presence on PM, and we performed a first experiment specifically aimed at confirming or excluding this research hyphotesys. METHODS: We have collected 34 PM10 samples in Bergamo area (the epicenter of the Italian COVID-19 epidemic) by using two air samplers over a continuous 3-weeks period. Filters were properly stored and underwent RNA extraction and amplification according to WHO protocols in two parallel blind analyses performed by two different authorized laboratories. Up to three highly specific molecular marker genes (E, N, and RdRP) were used to test the presence of SARS-CoV-2 RNA on particulate matter. RESULTS: The first test showed positive results for gene E in 15 out of 16 samples, simultaneously displaying positivity also for RdRP gene in 4 samples. The second blind test got 5 additional positive results for at least one of the three marker genes. Overall, we tested 34 RNA extractions for the E, N and RdRP genes, reporting 20 positive results for at least one of the three marker genes, with positivity separately confirmed for all the three markers. Control tests to exclude false positivities were successfully accomplished. CONCLUSION: This is the first evidence that SARS-CoV-2 RNA can be present on PM, thus suggesting a possible use as indicator of epidemic recurrence.
format Online
Article
Text
id pubmed-7260575
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-72605752020-06-01 SARS-Cov-2RNA found on particulate matter of Bergamo in Northern Italy: First evidence Setti, Leonardo Passarini, Fabrizio De Gennaro, Gianluigi Barbieri, Pierluigi Perrone, Maria Grazia Borelli, Massimo Palmisani, Jolanda Di Gilio, Alessia Torboli, Valentina Fontana, Francesco Clemente, Libera Pallavicini, Alberto Ruscio, Maurizio Piscitelli, Prisco Miani, Alessandro Environ Res Article BACKGROUND: The burden of COVID-19 was extremely severe in Northern Italy, an area characterized by high concentrations of particulate matter (PM), which is known to negatively affect human health. Consistently with evidence already available for other viruses, we initially hypothesized the possibility of SARS-CoV-2 presence on PM, and we performed a first experiment specifically aimed at confirming or excluding this research hyphotesys. METHODS: We have collected 34 PM10 samples in Bergamo area (the epicenter of the Italian COVID-19 epidemic) by using two air samplers over a continuous 3-weeks period. Filters were properly stored and underwent RNA extraction and amplification according to WHO protocols in two parallel blind analyses performed by two different authorized laboratories. Up to three highly specific molecular marker genes (E, N, and RdRP) were used to test the presence of SARS-CoV-2 RNA on particulate matter. RESULTS: The first test showed positive results for gene E in 15 out of 16 samples, simultaneously displaying positivity also for RdRP gene in 4 samples. The second blind test got 5 additional positive results for at least one of the three marker genes. Overall, we tested 34 RNA extractions for the E, N and RdRP genes, reporting 20 positive results for at least one of the three marker genes, with positivity separately confirmed for all the three markers. Control tests to exclude false positivities were successfully accomplished. CONCLUSION: This is the first evidence that SARS-CoV-2 RNA can be present on PM, thus suggesting a possible use as indicator of epidemic recurrence. Elsevier Inc. 2020-09 2020-05-30 /pmc/articles/PMC7260575/ /pubmed/32526492 http://dx.doi.org/10.1016/j.envres.2020.109754 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Setti, Leonardo
Passarini, Fabrizio
De Gennaro, Gianluigi
Barbieri, Pierluigi
Perrone, Maria Grazia
Borelli, Massimo
Palmisani, Jolanda
Di Gilio, Alessia
Torboli, Valentina
Fontana, Francesco
Clemente, Libera
Pallavicini, Alberto
Ruscio, Maurizio
Piscitelli, Prisco
Miani, Alessandro
SARS-Cov-2RNA found on particulate matter of Bergamo in Northern Italy: First evidence
title SARS-Cov-2RNA found on particulate matter of Bergamo in Northern Italy: First evidence
title_full SARS-Cov-2RNA found on particulate matter of Bergamo in Northern Italy: First evidence
title_fullStr SARS-Cov-2RNA found on particulate matter of Bergamo in Northern Italy: First evidence
title_full_unstemmed SARS-Cov-2RNA found on particulate matter of Bergamo in Northern Italy: First evidence
title_short SARS-Cov-2RNA found on particulate matter of Bergamo in Northern Italy: First evidence
title_sort sars-cov-2rna found on particulate matter of bergamo in northern italy: first evidence
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260575/
https://www.ncbi.nlm.nih.gov/pubmed/32526492
http://dx.doi.org/10.1016/j.envres.2020.109754
work_keys_str_mv AT settileonardo sarscov2rnafoundonparticulatematterofbergamoinnorthernitalyfirstevidence
AT passarinifabrizio sarscov2rnafoundonparticulatematterofbergamoinnorthernitalyfirstevidence
AT degennarogianluigi sarscov2rnafoundonparticulatematterofbergamoinnorthernitalyfirstevidence
AT barbieripierluigi sarscov2rnafoundonparticulatematterofbergamoinnorthernitalyfirstevidence
AT perronemariagrazia sarscov2rnafoundonparticulatematterofbergamoinnorthernitalyfirstevidence
AT borellimassimo sarscov2rnafoundonparticulatematterofbergamoinnorthernitalyfirstevidence
AT palmisanijolanda sarscov2rnafoundonparticulatematterofbergamoinnorthernitalyfirstevidence
AT digilioalessia sarscov2rnafoundonparticulatematterofbergamoinnorthernitalyfirstevidence
AT torbolivalentina sarscov2rnafoundonparticulatematterofbergamoinnorthernitalyfirstevidence
AT fontanafrancesco sarscov2rnafoundonparticulatematterofbergamoinnorthernitalyfirstevidence
AT clementelibera sarscov2rnafoundonparticulatematterofbergamoinnorthernitalyfirstevidence
AT pallavicinialberto sarscov2rnafoundonparticulatematterofbergamoinnorthernitalyfirstevidence
AT rusciomaurizio sarscov2rnafoundonparticulatematterofbergamoinnorthernitalyfirstevidence
AT piscitelliprisco sarscov2rnafoundonparticulatematterofbergamoinnorthernitalyfirstevidence
AT mianialessandro sarscov2rnafoundonparticulatematterofbergamoinnorthernitalyfirstevidence